Avalyn Pharma Inc. Common Stock
NASDAQ:AVLNMedical - Pharmaceuticals
+$0.52 today
- Market cap
- $1.23B
- Beta
- 0.00
Volume 0.40M
Average 0.51M
AVLN Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Operating Income history
Currency unavailable · from the income statement
No Operating Income data reported for this period type.
Operating Income vs competitors
How AVLN compares with its peers on the latest reported figures
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $13.4M USD | -82.9% | — | 3.7% | |
| LTM Mar 2026 | -$139K USD | -101.3% | +7.7% | 0.1% | |
VCREVicore Pharma Holding AB | LTM Jun 2026 | -SEK 285.35M SEK | +26.7% | — | 21455.4% |
| LTM Jun 2026 | -$817.54M USD | +18.6% | — | 71.9% | |
AVLNAvalyn Pharma Inc. Common Stock | — | — | — | — | — |
| Peer median (excluding AVLN) | — | -32.1% | +7.7% | 37.8% | |
Competitors are the stored peer set for AVLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Avalyn Pharma Inc. Common Stock
NASDAQ:AVLN
Intrinsic Alpha fair value
Locked
Current Price
$27.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.